alanyl-glutamyl-aspartyl-glycine has been researched along with Breast Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anisimov, VN | 1 |
Frantsiiants, EM; Khavinson, VKh; Musienko, NV; Sidorenko, IuS; Vladimirova, LIu | 1 |
Vladimirova, LIu; Zakora, GI; Zlamnik, EIu | 1 |
Buadze, T; Gaiozishvili, M; Jokhadze, T; Lezhava, T; Monaselidze, J; Nemsadze, G | 1 |
Alimova, IN; Anisimov, VN; Khavinson, VKh; Semchenko, AV; Yashin, AI | 1 |
5 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Breast Neoplasms
Article | Year |
---|---|
The role of pineal gland in breast cancer development.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Female; Humans; Light; Melatonin; Mice; Oligopeptides; Peptides; Pineal Gland; Rats | 2003 |
[Effect of epithalamin on free-radical reactions in the formed elements of blood from breast cancer patients].
Topics: Adult; Aged; Antineoplastic Agents; Antioxidants; Blood Cells; Breast Neoplasms; Female; Free Radical Scavengers; Free Radicals; Humans; Middle Aged; Peptides; Vitamins | 2003 |
[Optimal conditions for producing immunomodulating effect of epithalamine as component of neoadjuvant chemotherapy using autoplasma and autoblood in patients with locally advanced breast cancer].
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Immunity, Cellular; Middle Aged; Peptides | 2004 |
[GENOMIC VARIABILITY IN PATIENTS WITH DUCTAL FORM OF BREAST CANCER AND THE POSSIBILITY OF CORRECTION THE PEPTIDE BIOREGULATOR AND METAL IONS].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cations, Divalent; Chromatin; Chromosome Aberrations; Chromosome Fragile Sites; Drug Synergism; Female; Genetic Variation; Humans; Nickel; Oligopeptides; Tumor Cells, Cultured | 2017 |
Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice.
Topics: Adenocarcinoma; Aging; Animals; Breast Neoplasms; Mice; Mice, Transgenic; Oligopeptides; Receptor, ErbB-2 | 2002 |